{"filings":[{"id":759758,"accession_number":"0001493152-26-026533","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-06-01T12:05:42+00:00","items":["7.01","9.01"],"status":"ready","headline":"Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.","SCPL's existing sublicense partners include Eris, Dr. Reddy's, Cipla, Dabur, Glenmark for Hair Enzyme Booster in multiple Asian and Middle Eastern markets.","Photocil (commercialized as Photofirst by Eris) is a patented topical for vitiligo, psoriasis, and atopic dermatitis.","Hair Enzyme Booster is a first-of-its-kind topical that increases SULT1A1 enzyme to convert Minoxidil into active form for hair growth.","CEO Glynn Wilson stated the expanded agreement reflects confidence in SCPL and aims to improve revenue stream."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":749278,"accession_number":"0001493152-26-026451","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-05-29T21:29:56+00:00","items":["8.01"],"status":"ready","headline":"Caring Brands corrects record date in proxy statement - May 14, not May 12","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Prior proxy statement (May 12, 2026) incorrectly listed May 12, 2026 as record date for annual meeting.","Correct record date is May 14, 2026; only stockholders of record on that date can vote.","Company will file a revised definitive proxy statement to correct the error.","All other information in the proxy statement remains unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97251,"accession_number":"0001493152-26-016171","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-04-10T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Caring Brands receives Nasdaq delisting notice for equity shortfall; stock continues trading","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' equity of $2,091,324 reported in FY2025 10-K, below Nasdaq's $2.5M minimum requirement.","Company has 45 days (until May 22, 2026) to submit a compliance plan to Nasdaq.","If plan accepted, Nasdaq may grant up to 180 days (until Oct 4, 2026) to regain compliance.","Common stock continues trading under symbol CABR with no immediate delisting effect.","Company plans to take measures but cannot assure plan acceptance or compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111861,"accession_number":"0001493152-26-013808","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["3.03","5.02","5.03","9.01"],"status":"ready","headline":"Caring Brands reduces shareholder quorum to 33.33% and names Brian John interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bylaw amendment cuts quorum for shareholder meetings from majority to 33.33% of outstanding shares.","Brian John, current Chairman and CIO, appointed Interim CFO effective March 30, 2026.","No material changes to John's compensation in connection with the appointment.","Amendment to Bylaws filed as Exhibit 3.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111860,"accession_number":"0001493152-26-012418","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["1.01","3.02","3.03","9.01"],"status":"ready","headline":"Caring Brands closes $3.6M PIPE with Series A Preferred and warrants; redeems 6.25M insider shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 3,789.74 Series A Preferred shares (stated value $1,000 each) and 9,473,685 warrants at $0.40 exercise price for $3.6M gross.","$3.075M of proceeds used to buy back 6,250,000 common shares from CEO, Chairman, and NovoDX; shares outstanding drop from 14.76M to 8.51M.","Series A Preferred pays 8% dividend (cash or common stock) and is convertible into common at $0.40 per share.","Purchaser receives additional investment right (AIR) to buy up to $4.0M of same securities at a discount to market price.","Warrants are exercisable for 5 years, with a 4.99% beneficial ownership limitation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111859,"accession_number":"0001493152-26-004846","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Caring Brands receives two U.S. patents for hair enzyme booster technology","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Two new U.S. patents granted Jan 2026 covering methods to increase sulfotransferase enzyme activity for topical hair loss treatments.","Patents strengthen IP portfolio for Hair Enzyme Booster, currently generating revenue via direct U.S. sales and international licensees.","CEO Dr. Glynn Wilson says patents validate scientific foundation and enhance competitive moat for hair and skin health strategy.","Company expects to provide further updates on product development, distribution expansion, and leveraging growing patent portfolio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111858,"accession_number":"0001493152-26-001128","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-01-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Caring Brands CFO Tyler Moore resigns; search for successor underway","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tyler Moore resigned as CFO on January 5, 2026, not due to any disagreement with the company.","Board has commenced a search to fill the CFO position; expects to appoint a successor in near term.","Interim financial and reporting functions will be managed by existing team."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111857,"accession_number":"0001493152-26-000286","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2026-01-05T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Caring Brands enters exclusive global license for Emesyl nausea relief product","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Licensed Emesyl OTC nausea product from Itonis; exclusive worldwide rights to manufacture, market, distribute.","8% royalty on net sales; potential to earn 7% of Itonis equity per $200k in sales.","License may terminate if sales ≤$25k for four consecutive quarters after launch.","Global nausea treatment market projected >$6.23B in 2025, per QY Research.","CEO notes expansion of health/wellness portfolio; further updates expected on timelines."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128490,"accession_number":"0001493152-25-023919","cik":2020737,"company_name":"Caring Brands, Inc.","ticker":"CABR","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Caring Brands raises $4M in IPO, lists on Nasdaq under 'CABR'","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 1,000,000 shares at $4.00; gross proceeds $4M, net ~$3.23M.","Granted underwriter 45-day option for up to 150,000 additional shares at $4.00.","Issued underwriter warrant for 30,000 shares (exercisable at $4.00 for 5 years).","Stock began trading on Nasdaq Capital Market on Nov 13, 2025; moved from OTCQB.","Proceeds for working capital, marketing, product sales, and debt repayment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8359999.999999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}